Humatrope Purple Book BLA 019640
- BLA number
- 019640
- Proprietary names
- Humatrope
- Proper names
- somatropin
- Applicant
- Eli Lilly and Company
- Center
- CDER
- First observed release
- 2020-05-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- No patents listed in the captured FDA patent list; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | Humatrope | somatropin | 351(a) | 2MG | For Injection | Subcutaneous | Single-Dose Vial | Disc | Licensed | 1987-06-23 | |
| 004 | Humatrope | somatropin | 351(a) | 5MG | For Injection | Subcutaneous | Single-Dose Vial | Disc | Licensed | 1986-10-16 | |
| 005 | Humatrope | somatropin | 351(a) | 6MG | For Injection | Subcutaneous | Multi-Dose Cartridge | Rx | Licensed | 1999-02-04 | |
| 006 | Humatrope | somatropin | 351(a) | 12MG | For Injection | Subcutaneous | Multi-Dose Cartridge | Rx | Licensed | 1999-02-04 | |
| 007 | Humatrope | somatropin | 351(a) | 24MG | For Injection | Subcutaneous | Multi-Dose Cartridge | Rx | Licensed | 1999-02-04 | |
Published Patent List#
No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2026-04-01 | U | 001 | Humatrope | 351(a) | Disc | Eli Lilly and Company |
| 2026-04-01 | U | 004 | Humatrope | 351(a) | Disc | Eli Lilly and Company |
| 2026-04-01 | U | 005 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2026-04-01 | U | 006 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2026-04-01 | U | 007 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2023-07-01 | U | 004 | Humatrope | 351(a) | Disc | Eli Lilly and Company |
| 2022-09-01 | U | 001 | Humatrope | 351(a) | Disc | Eli Lilly and Company |
| 2022-09-01 | U | 004 | Humatrope | 351(a) | Disc | Eli Lilly and Company |
| 2021-07-01 | U | 004 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2021-04-01 | U | 004 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-08-01 | U | 001 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-08-01 | U | 004 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-08-01 | U | 005 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-08-01 | U | 006 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-08-01 | U | 007 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-05-01 | R | 001 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-05-01 | R | 004 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-05-01 | R | 005 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-05-01 | R | 006 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
| 2020-05-01 | R | 007 | Humatrope | 351(a) | Rx | Eli Lilly and Company |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2023-07-01 | 004 | Humatrope | 351(a) | Disc | Licensed | 1986-10-16 |
| 2022-10-01 | 004 | Humatrope | 351(a) | Rx | Licensed | 1986-10-16 |
| 2022-09-01 | 001 | Humatrope | 351(a) | Disc | Licensed | 1987-06-23 |
| 2022-09-01 | 004 | Humatrope | 351(a) | Disc | Licensed | 1986-10-16 |
| 2021-07-01 | 004 | Humatrope | 351(a) | Rx | Licensed | 1986-10-16 |
| 2020-05-01 | 001 | Humatrope | 351(a) | Rx | Licensed | 1987-06-23 |
| 2020-05-01 | 004 | Humatrope | 351(a) | Rx | Licensed | |
| 2020-05-01 | 005 | Humatrope | 351(a) | Rx | Licensed | 1999-02-04 |
| 2020-05-01 | 006 | Humatrope | 351(a) | Rx | Licensed | 1999-02-04 |
| 2020-05-01 | 007 | Humatrope | 351(a) | Rx | Licensed | 1999-02-04 |